222 related articles for article (PubMed ID: 26619025)
1. Expression of Angiogenic Factors in Invasive Retinoblastoma Tumors Is Associated With Increase in Tumor Cells Expressing Stem Cell Marker Sox2.
Garcia JR; Gombos DS; Prospero CM; Ganapathy A; Penland RL; Chévez-Barrios P
Arch Pathol Lab Med; 2015 Dec; 139(12):1531-8. PubMed ID: 26619025
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of retinoblastoma cell phenotype using neuronal and glial cell markers.
Orellana ME; Belfort R; Antecka E; Burnier MN
Arq Bras Oftalmol; 2016; 79(6):395-399. PubMed ID: 28076568
[TBL] [Abstract][Full Text] [Related]
3. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours.
Stitt AW; Simpson DA; Boocock C; Gardiner TA; Murphy GM; Archer DB
J Pathol; 1998 Nov; 186(3):306-12. PubMed ID: 10211121
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of stem cell markers and vascular endothelial growth factor in human retinoblastoma tissue.
Kim M; Kim JH; Kim JH; Kim DH; Yu YS
Korean J Ophthalmol; 2010 Feb; 24(1):35-9. PubMed ID: 20157412
[TBL] [Abstract][Full Text] [Related]
5. Leucine-Rich α-2-Glycoprotein-1 (LRG-1) Expression in Retinoblastoma.
Amer R; Tiosano L; Pe'er J
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):685-692. PubMed ID: 29392314
[TBL] [Abstract][Full Text] [Related]
6. Histopathological features and P-glycoprotein expression in retinoblastoma.
Filho JP; Correa ZM; Odashiro AN; Coutinho AB; Martins MC; Erwenne CM; Burnier MN
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3478-83. PubMed ID: 16186322
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of CD117 and vascular endothelial growth factor in retinoblastoma: possible targets of new therapies.
Youssef NS; Said AM
Int J Clin Exp Pathol; 2014; 7(9):5725-37. PubMed ID: 25337214
[TBL] [Abstract][Full Text] [Related]
8. Cancer Stem Cells with Overexpression of Neuronal Markers Enhance Chemoresistance and Invasion in Retinoblastoma.
Balaji S; Santhi R; Kim U; Muthukkaruppan V; Priya CG; Vanniarajan A
Curr Cancer Drug Targets; 2020; 20(9):710-719. PubMed ID: 32364077
[TBL] [Abstract][Full Text] [Related]
9. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
[TBL] [Abstract][Full Text] [Related]
10. Expression of vascular endothelial growth factor in retinoblastoma.
Areán C; Orellana ME; Abourbih D; Abreu C; Pifano I; Burnier MN
Arch Ophthalmol; 2010 Feb; 128(2):223-9. PubMed ID: 20142546
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous tumor vasculature in retinoblastoma: implications for vessel targeting therapy.
Jockovich ME; Piña Y; Alegret A; Cebulla C; Feuer W; Murray TG
Retina; 2008 Mar; 28(3 Suppl):S81-6. PubMed ID: 18317352
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of high-risk features of primary enucleation of patients with retinoblastoma in a tertiary center of a developing country in the era of intra-arterial chemotherapy.
Dikkaya F; Sarıcı AM; Erbek F; Celkan T; Mangan MS; Aydın Ö; Demirkesen C; Pazarlı H
Int Ophthalmol; 2018 Feb; 38(1):151-156. PubMed ID: 28058667
[TBL] [Abstract][Full Text] [Related]
13. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.
Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM
Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964
[TBL] [Abstract][Full Text] [Related]
14. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features.
Bunone G; Vigneri P; Mariani L; Butó S; Collini P; Pilotti S; Pierotti MA; Bongarzone I
Am J Pathol; 1999 Dec; 155(6):1967-76. PubMed ID: 10595926
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathologic features of retinoblastoma and expression of VEGF and Ki-67 after comprehensive treatment].
Xue K; Qian J; Bi YW; Yao YQ; Yuan YF; DA CD
Zhonghua Yan Ke Za Zhi; 2011 Feb; 47(2):134-41. PubMed ID: 21426843
[TBL] [Abstract][Full Text] [Related]
16. Angiogenetic protooncogene ets-1 induced neovascularization is involved in the metastatic process of testicular germ cell tumors.
Adam M; Schmidt D; Wardelmann E; Wernert N; Albers P
Eur Urol; 2003 Sep; 44(3):329-36. PubMed ID: 12932931
[TBL] [Abstract][Full Text] [Related]
17. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF.
Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y
Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of angiogenesis associated factors of retinoblastoma cell line and tumor tissues].
Wu JH; Xu P; Yi MY; Wang F; Wang XL; Huang Q
Zhonghua Yan Ke Za Zhi; 2005 May; 41(5):419-22. PubMed ID: 15938806
[TBL] [Abstract][Full Text] [Related]
19. EpCAM expression in retinoblastoma: a novel molecular target for therapy.
Krishnakumar S; Mohan A; Mallikarjuna K; Venkatesan N; Biswas J; Shanmugam MP; Ren-Heidenreich L
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4247-50. PubMed ID: 15557427
[TBL] [Abstract][Full Text] [Related]
20. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
Basilio-de-Oliveira RP; Pannain VL
World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
